These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8536898)

  • 1. A comparison of nonionic versus ionic contrast media: results of a prospective, multicenter study. Midwest Pancreaticobiliary Study Group.
    Johnson GK; Geenen JE; Bedford RA; Johanson J; Cass O; Sherman S; Hogan WJ; Ryan M; Silverman W; Edmundowicz S
    Gastrointest Endosc; 1995 Oct; 42(4):312-6. PubMed ID: 8536898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of post-ERCP pancreatitis: potential causes noted during controlled study of differing contrast media. Midwest Pancreaticobiliary Study Group.
    Johnson GK; Geenen JE; Johanson JF; Sherman S; Hogan WJ; Cass O
    Gastrointest Endosc; 1997 Sep; 46(3):217-22. PubMed ID: 9378207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for post-ERCP pancreatitis: a prospective multicenter study.
    Cheng CL; Sherman S; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Lazzell-Pannell L; Rashdan A; Temkit M; Lehman GA
    Am J Gastroenterol; 2006 Jan; 101(1):139-47. PubMed ID: 16405547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of ionic, monomer, high osmolar contrast media with non-ionic, dimer, iso-osmolar contrast media in ERCP.
    Ogawa M; Kawaguchi Y; Kawashima Y; Mizukami H; Maruno A; Ito H; Mine T
    Tokai J Exp Clin Med; 2013 Sep; 38(3):109-13. PubMed ID: 24030487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study.
    Sherman S; Blaut U; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Earle D; Temkit M; Lehman GA
    Gastrointest Endosc; 2003 Jul; 58(1):23-9. PubMed ID: 12838216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trial of low versus high osmolar contrast media in endoscopic retrograde cholangiopancreatography.
    Banerjee AK; Grainger SL; Thompson RP
    Br J Clin Pract; 1990 Nov; 44(11):445-7. PubMed ID: 2282293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-ERCP pancreatitis: randomized, prospective study comparing a low- and high-osmolality contrast agent.
    Sherman S; Hawes RH; Rathgaber SW; Uzer MF; Smith MT; Khusro QE; Silverman WB; Earle DT; Lehman GA
    Gastrointest Endosc; 1994; 40(4):422-7. PubMed ID: 7926531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the Use of Low Osmolality Contrast Medium Reduce the Frequency of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Comparative Study between Use of Low and High Osmolality Contrast Media.
    Nagashima K; Ijima M; Kimura K; Kurihara E; Tominaga K; Fukushi K; Kanamori A; Otake Y; Irisawa A
    Digestion; 2021; 102(2):283-288. PubMed ID: 31770751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis.
    Rabenstein T; Fischer B; Wiessner V; Schmidt H; Radespiel-Tröger M; Hochberger J; Mühldorfer S; Nusko G; Messmann H; Schölmerich J; Schulz HJ; Schönekäs H; Hahn EG; Schneider HT
    Gastrointest Endosc; 2004 May; 59(6):606-13. PubMed ID: 15114301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and predictors of post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction undergoing biliary or dual sphincterotomy: results from the EPISOD prospective multicenter randomized sham-controlled study.
    Yaghoobi M; Pauls Q; Durkalski V; Romagnuolo J; Fogel EL; Tarnasky PR; Aliperti G; Freeman ML; Kozarek RA; Jamidar PA; Wilcox CM; Elta GH; Hawes RH; Wood-Williams A; Cotton PB
    Endoscopy; 2015 Oct; 47(10):884-90. PubMed ID: 26165739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for complications after performance of ERCP.
    Vandervoort J; Soetikno RM; Tham TC; Wong RC; Ferrari AP; Montes H; Roston AD; Slivka A; Lichtenstein DR; Ruymann FW; Van Dam J; Hughes M; Carr-Locke DL
    Gastrointest Endosc; 2002 Nov; 56(5):652-6. PubMed ID: 12397271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone.
    Fogel EL; Eversman D; Jamidar P; Sherman S; Lehman GA
    Endoscopy; 2002 Apr; 34(4):280-5. PubMed ID: 11932782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study.
    Testoni PA; Mariani A; Giussani A; Vailati C; Masci E; Macarri G; Ghezzo L; Familiari L; Giardullo N; Mutignani M; Lombardi G; Talamini G; Spadaccini A; Briglia R; Piazzi L;
    Am J Gastroenterol; 2010 Aug; 105(8):1753-61. PubMed ID: 20372116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral udenafil and aceclofenac for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a randomized multicenter study.
    Lee TY; Choi JS; Oh HC; Song TJ; Do JH; Cheon YK
    Korean J Intern Med; 2015 Sep; 30(5):602-9. PubMed ID: 26354054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute pancreatitis following endoscopic retrograde cholangiopancreatography.
    Hamilton I; Lintott DJ; Rothwell J; Axon AT
    Clin Radiol; 1983 Sep; 34(5):543-6. PubMed ID: 6617085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study.
    Freeman ML; DiSario JA; Nelson DB; Fennerty MB; Lee JG; Bjorkman DJ; Overby CS; Aas J; Ryan ME; Bochna GS; Shaw MJ; Snady HW; Erickson RV; Moore JP; Roel JP
    Gastrointest Endosc; 2001 Oct; 54(4):425-34. PubMed ID: 11577302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis.
    Tarnasky P; Cunningham J; Cotton P; Hoffman B; Palesch Y; Freeman J; Curry N; Hawes R
    Endoscopy; 1997 May; 29(4):252-7. PubMed ID: 9255527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does obesity confer an increased risk and/or more severe course of post-ERCP pancreatitis?: a retrospective, multicenter study.
    Deenadayalu VP; Blaut U; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Temkit M; Lehman GA; Sherman S
    J Clin Gastroenterol; 2008; 42(10):1103-9. PubMed ID: 18936645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidewire biliary cannulation does not reduce post-ERCP pancreatitis compared with the contrast injection technique in low-risk and high-risk patients.
    Mariani A; Giussani A; Di Leo M; Testoni S; Testoni PA
    Gastrointest Endosc; 2012 Feb; 75(2):339-46. PubMed ID: 22075192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.